Renzapride
Title: Renzapride
CAS Registry Number: 112727-80-7
CAS Name: rel-4-Amino-N-(1R,4S,5R)-1-azabicyclo[3.3.1]non-4-yl-5-chloro-2-methoxybenzamide
Additional Names: (±)-endo-4-amino-5-chloro-2-methoxy-N-(1-azabicyclo[3.3.1]non-4-yl)benzamide
Manufacturers' Codes: ATL-1251; BRL-24924
Molecular Formula: C16H22ClN3O2
Molecular Weight: 323.82
Percent Composition: C 59.35%, H 6.85%, Cl 10.95%, N 12.98%, O 9.88%
Literature References: Serotonin receptor 5-HT4 agonist/5-HT3 antagonist. Prepn: F. D. King, EP 94742; idem, US 4612319 (1983, 1986 both to Beecham); idem et al., J. Med. Chem. 36, 683 (1993). 5-HT4 receptor selectivity as quaternary salt: G. S. Baxter et al., Bioorg. Med. Chem. Lett. 3, 633 (1993). Clinical pharmacology: D. H. Staniforth, M. Pennick, Eur. J. Clin. Pharmacol. 38, 161 (1990). Clinical evaluation in irritable bowel syndrome: M. Camilleri et al., Clin. Gastroenterol. Hepatol. 2, 895 (2004). Review: P. Norman, Curr. Opin. Cent. Peripher. Nerv. Syst. Invest. Drugs 2, 355-368 (2000).
Properties: mp >260°.
Melting point: mp >260°
Therap-Cat: Gastroprokinetic. In treatment of irritable bowel syndrome.
Keywords: Gastroprokinetic.

Others monographs:
DicloxacillinPotassium BifluorideQuercetagetinFluoroform
Potassium MetabisulfiteDiethylbromoacetamideKetanserinTMD
IobenguaneN-BromosuccinimideInsulin GlulisineAcetoin
Magnesium StearateBuprofezinDiazoaminobenzeneSodium Bromide
©2016 DrugLead US FDA&EMEA